ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature. (Q47929063)
Jump to navigation
Jump to search
scientific article published in July 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature. |
scientific article published in July 2009 |
Statements
ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature (English)
Yanping Luo
David J Frost
Saul H Rosenberg
Gary B Gordon
Sherry J Morgan
Gerard D Gagne
Bryan F Cox
Stephen K Tahir